TSPO and early-onset autosomal dominant Alzheimer disease: Another study has revealed that the use of the TSPO ligands PK11195 and Ro5-4864 can dramatically reduce neural damage and glial cell activity in Alzheimer’s disease transgenic mouse models [30].